β-Nicotinamide mononucleotide, reduced form disodium

SKU: orb3142019

Description

β-Nicotinamide mononucleotide, reduced form (NMNH) disodium is the reduced variant of β-Nicotinamide mononucleotide, with oral bioavailability. This compound significantly increases NAD+ and NADH levels while inhibiting glycolysis, the tricarboxylic acid cycle, and cell growth, mechanisms that are dependent on nicotinamide mononucleotide adenylyltransferase (NMNAT).

Research Area

Pharmacology & Drug Discovery

Key Properties

• CAS Number: 108347-85-9
• MW: 380.20
• Formula: C₁₁H₁₅N₂Na₂O₈P
• SMILES: O[C@H]1[C@H](N2C=C(CC=C2)C(N)=O)O[C@@H]([C@H]1O)COP([O-])([O-])=O.[Na+].[Na+]
• Target: Endogenous Metabolite

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

Endogenous Metabolite